Validation of prognostic signature and exploring the immune-related mechanisms for <i>NR3C2</i> in clear cell renal cell carcinoma.

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-846/coif). The authors have no conflicts of interest to declare."

"Funding: The study was supported by the Natural Science Foundation of Fujian Province, China ( No. 2022J01122348 ), the Natural Science Foundation of Fujian Province, China ( No. 2022 J01312324 ), the Health Commission of Fujian Province Young & Middle-Aged Medical Backbone Talents Project ( No.2020GGA077 ), the Natural Science Foundation of Fujian Province ( No. 2020J01126 ), the Sailing Fund of Fujian Medical University ( No. 2018QH1164 ) and the Scientific Fund of Sanming Science and Technology Bureau ( No. 2018-5-1(7) )."